About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Tuberculosis
›
top-articles
Tuberculosis
2.6
(top 20%)
impact factor
1.9K
(top 10%)
papers
50.6K
(top 10%)
citations
93
(top 5%)
h
-index
2.7
(top 20%)
impact factor
2.2K
all documents
54.6K
doc citations
134
(top 10%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis
Tuberculosis
2003
664
2
M. tuberculosis persistence, latency, and drug tolerance
Tuberculosis
2004
467
3
Mycobacterium tuberculosis gene expression during adaptation to stationary phase and low-oxygen dormancy
Tuberculosis
2004
410
4
TubercuList – 10 years after
Tuberculosis
2011
387
5
The MycoBrowser portal: A comprehensive and manually annotated resource for mycobacterial genomes
Tuberculosis
2011
355
6
Human Mycobacterium bovis infection in the United Kingdom: Incidence, risks, control measures and review of the zoonotic aspects of bovine tuberculosis
Tuberculosis
2006
346
7
Iron, mycobacteria and tuberculosis
Tuberculosis
2004
287
8
The global situation of MDR-TB
Tuberculosis
2003
274
9
Volatile biomarkers of pulmonary tuberculosis in the breath
Tuberculosis
2007
274
10
Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis
Tuberculosis
2005
273
11
Immunology of tuberculosis and implications in vaccine development
Tuberculosis
2004
256
12
High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv
Tuberculosis
2009
251
13
Oral solid lipid nanoparticle-based antitubercular chemotherapy
Tuberculosis
2005
230
14
Neutrophil extracellular traps are induced by Mycobacterium tuberculosis
Tuberculosis
2009
227
15
Mycobacterium bovis infection in human beings
Tuberculosis
2001
224
16
Tuberculosis: A disease without boundaries
Tuberculosis
2015
223
17
The TB epidemic from 1992 to 2002
Tuberculosis
2003
221
18
Breath biomarkers of active pulmonary tuberculosis
Tuberculosis
2010
211
19
Pathology of post primary tuberculosis of the lung: An illustrated critical review
Tuberculosis
2011
207
20
Current findings, challenges and novel approaches in human genetic susceptibility to tuberculosis
Tuberculosis
2010
201
21
Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosis
Tuberculosis
2012
193
22
Gene expression profile of Mycobacterium tuberculosis in a non-replicating state
Tuberculosis
2004
187
23
Stationary phase gene expression of Mycobacterium tuberculosis following a progressive nutrient depletion: a model for persistent organisms?
Tuberculosis
2004
185
24
Pathology of postprimary tuberculosis in humans and mice: Contradiction of long-held beliefs
Tuberculosis
2007
184
25
Nanoparticle encapsulated antitubercular drugs as a potential oral drug delivery system against murine tuberculosis
Tuberculosis
2003
183
26
BOVIGAMTM: an in vitro cellular diagnostic test for bovine tuberculosis
Tuberculosis
2001
176
27
Cerebrospinal fluid concentrations of antituberculosis agents in adults and children
Tuberculosis
2010
176
28
Azole resistance in Mycobacterium tuberculosis is mediated by the MmpS5–MmpL5 efflux system
Tuberculosis
2009
161
29
Control of human host immunity to mycobacteria
Tuberculosis
2005
158
30
Cutaneous tuberculosis overview and current treatment regimens
Tuberculosis
2015
157
31
Host blood RNA signatures predict the outcome of tuberculosis treatment
Tuberculosis
2017
156
32
Rifamycins – Obstacles and opportunities
Tuberculosis
2010
155
33
Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis
Tuberculosis
2005
154
34
Point-of-care breath test for biomarkers of active pulmonary tuberculosis
Tuberculosis
2012
153
35
Inhaled drug therapy for treatment of tuberculosis
Tuberculosis
2011
149
36
Genetic polymorphisms of NAT2 and CYP2E1 associated with antituberculosis drug-induced hepatotoxicity in Korean patients with pulmonary tuberculosis
Tuberculosis
2007
148
37
Mycobacterium bovis in rural Tanzania: Risk factors for infection in human and cattle populations
Tuberculosis
2007
146
38
The scent of Mycobacterium tuberculosis
Tuberculosis
2008
146
39
Identification of outer membrane proteins of Mycobacterium tuberculosis
Tuberculosis
2008
143
40
Tuberculosis as a three-act play: A new paradigm for the pathogenesis of pulmonary tuberculosis
Tuberculosis
2016
141
41
The mechanisms and consequences of the extra-pulmonary dissemination of Mycobacterium tuberculosis
Tuberculosis
2010
139
42
Mycobacterium tuberculosis Beijing genotype: A template for success
Tuberculosis
2011
139
43
Antituberculosis activity of the molecular libraries screening center network library
Tuberculosis
2009
138
44
Human immunity to M. tuberculosis: T cell subsets and antigen processing
Tuberculosis
2003
137
45
RUTI: A new chance to shorten the treatment of latent tuberculosis infection
Tuberculosis
2006
135
46
Antibodies and tuberculosis
Tuberculosis
2016
131
47
The scent of Mycobacterium tuberculosis – Part II breath
Tuberculosis
2009
128
48
The influence of reduced oxygen availability on pathogenicity and gene expression in Mycobacterium tuberculosis
Tuberculosis
2004
127
49
Unusual features of the cell cycle in mycobacteria: Polar-restricted growth and the snapping-model of cell division
Tuberculosis
2007
127
50
Diversity in Mycobacterium tuberculosis mannosylated cell wall determinants impacts adaptation to the host
Tuberculosis
2010
127
site/software ©
exaly
; All materials licenced under
CC by-SA
.